<table id="table6" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 6	Effect of Coadministered Drugs on Saquinavir Pharmacokinetics</caption>
<col align="left" valign="top" width="35%"></col>
<col align="left" valign="top" width="20%"></col>
<col align="center" valign="top" width="5%"></col>
<col align="center" valign="top" width="20%"></col>
<col align="center" valign="top" width="20%"></col>
<tfoot>
<tr>
<td align="left" colspan="5">↑	Denotes an average increase in exposure by the percentage indicated.</td>
</tr>
<tr>
<td align="left" colspan="5">↓	Denotes an average decrease in exposure by the percentage indicated.</td>
</tr>
<tr>
<td align="left" colspan="5">↔	Mean change &lt;10%</td>
</tr>
<tr>
<td align="left" colspan="5">S	Subjects</td>
</tr>
<tr>
<td align="left" colspan="5">V	Healthy Volunteers</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Lrule Rrule">
<content stylecode="bold">Coadministered Drug</content>
</td>
<td align="center" stylecode="Rrule">
<content stylecode="bold">Saquinavir soft gel capsules</content>
</td>
<td stylecode="Rrule">
<content stylecode="bold">N</content>
</td>
<td colspan="2" stylecode="Rrule">
<content stylecode="bold">% Change for Saquinavir</content>
</td>
</tr>
<tr stylecode="Toprule">
<td stylecode="Lrule Rrule"></td>
<td align="center" stylecode="Rrule">
<content stylecode="bold">Dose</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule Toprule">
<content stylecode="bold">AUC (95% CI)</content>
</td>
<td stylecode="Rrule Toprule">
<content stylecode="bold">C<sub>max</sub> (95% CI)</content>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Toprule">Clarithromycin 500 mg bid × 7 days</td>
<td stylecode="Rrule Toprule">1200 mg tid × 7 days</td>
<td stylecode="Rrule Toprule">12V</td>
<td stylecode="Rrule Toprule">↑177% (108-269%)</td>
<td stylecode="Rrule Toprule">↑187% (105-300%)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Toprule">Efavirenz 600 mg qd</td>
<td stylecode="Rrule Toprule">1200 mg tid</td>
<td stylecode="Rrule Toprule Botrule">13V</td>
<td stylecode="Rrule Toprule">↓62%</td>
<td stylecode="Rrule Toprule Botrule">↓50%</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Toprule">Indinavir 800 mg q8h × 2 days</td>
<td stylecode="Rrule Toprule">1200 mg single dose</td>
<td stylecode="Rrule Botrule">6V</td>
<td stylecode="Rrule Toprule">↑364% (190-644%)</td>
<td stylecode="Rrule Botrule">↑299% (138-568%)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule Toprule">Ritonavir 400 mg bid × 14 days</td>
<td stylecode="Rrule Toprule">400 mg bid × 14 days<footnote id="tb6ft1">Compared to saquinavir soft gel capsules 1200 mg tid regimen (n=33).</footnote>
</td>
<td stylecode="Rrule">8V</td>
<td stylecode="Rrule Toprule">↑121% (7-359%)</td>
<td stylecode="Rrule">↑64%<footnote>Did not reach statistical significance.</footnote>
</td>
</tr>
<tr stylecode="Botrule">
<td colspan="5" stylecode="Lrule Rrule">Lopinavir/ritonavir<br/>Evidence from several clinical trials indicates that saquinavir concentrations achieved with saquinavir 1000 mg + lopinavir/ritonavir 400/100 mg BID are similar to those achieved following saquinavir/ritonavir 1000/100 mg BID.</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">
<content stylecode="bold">Coadministered Drug</content>
</td>
<td align="center" stylecode="Rrule">
<content stylecode="bold">INVIRASE or INVIRASE/ritonavir</content>
</td>
<td stylecode="Rrule">
<content stylecode="bold">N</content>
</td>
<td colspan="2" stylecode="Rrule">
<content stylecode="bold">% Change for Saquinavir</content>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Botrule"></td>
<td align="center" stylecode="Rrule Botrule">
<content stylecode="bold">Dose</content>
</td>
<td stylecode="Rrule Botrule"></td>
<td stylecode="Rrule Toprule">
<content stylecode="bold">AUC (95% CI)</content>
</td>
<td stylecode="Rrule Toprule">
<content stylecode="bold">C<sub>max</sub> (95% CI)</content>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Botrule">Atazanavir 300 mg qd</td>
<td stylecode="Rrule Botrule">1600/100 mg qd</td>
<td stylecode="Rrule Botrule">18S</td>
<td stylecode="Rrule Toprule">↑60%<br/>(16-122%)</td>
<td stylecode="Rrule Toprule">↑42%<br/>(10-84%)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule Botrule">Fosamprenavir 700 mg bid</td>
<td stylecode="Rrule Botrule">1000 mg bid/100 mg bid</td>
<td stylecode="Rrule Botrule">18S</td>
<td stylecode="Rrule Toprule">↓15%<br/>(-33% to 9%)</td>
<td stylecode="Rrule Toprule">↔<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ritonavir 100 mg bid</td>
<td stylecode="Rrule">1000 mg bid<footnote>Compared to INVIRASE 600 mg tid regimen (n=114).</footnote>
</td>
<td stylecode="Rrule">24S</td>
<td stylecode="Rrule Toprule">↑1124%</td>
<td stylecode="Rrule Toprule">↑1325%</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Tenofovir 300 mg qd</td>
<td stylecode="Rrule">1000 mg bid/100 mg bid</td>
<td stylecode="Rrule">18S</td>
<td stylecode="Rrule">↔<br/>
</td>
<td stylecode="Rrule">↔<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Tipranavir 500 mg + ritonavir 200 mg bid</td>
<td stylecode="Rrule">600 mg bid/100 mg bid</td>
<td stylecode="Rrule">20S</td>
<td stylecode="Rrule">↓76%<br/>(68-81%)<footnote id="tb6ft5">90% Confidence Interval</footnote>
</td>
<td stylecode="Rrule">↓70%<br/>(60-77%)<footnoteref idref="tb6ft5"></footnoteref>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Omeprazole 40 mg   qd × 5 days</td>
<td stylecode="Rrule">1000/100 mg bid × 15 days</td>
<td stylecode="Rrule">19V</td>
<td stylecode="Rrule">↑82%<br/>(37-234%)<footnoteref idref="tb6ft5"></footnoteref>
</td>
<td stylecode="Rrule">↑ 75%<br/>(31-234%)<footnoteref idref="tb6ft5"></footnoteref>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ketoconazole 200 mg/day</td>
<td stylecode="Rrule">1000 mg bid/100 mg bid</td>
<td stylecode="Rrule">20V</td>
<td stylecode="Rrule">↔<footnoteref idref="tb6ft5"></footnoteref>
</td>
<td stylecode="Rrule">↔</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Rifabutin 150 mg q3d</td>
<td stylecode="Rrule">1000 mg bid/100 mg bid</td>
<td stylecode="Rrule">19V</td>
<td stylecode="Rrule">↓13%<br/>(-31% to 9%)<footnoteref idref="tb6ft5"></footnoteref>
</td>
<td stylecode="Rrule">↓15%<br/>(-32% to 7%)<footnoteref idref="tb6ft5"></footnoteref>
</td>
</tr>
</tbody>
</table>